Addex Therapeutics reported cash from operations of -$0.98M and free cash flow of -$0.98M for the quarter ended Mar 2026, down 46.9% year over year. This cash flow statement covers 31 quarters of results from Dec 2017 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2017 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||||
| Net Income | -5.14M | -3.92M | -4.80M | -6.31M | -7.50M | -4.25M | 6.59M | -2.60M | -2.98M | -2.96M | -10.09M | -3.54M | 14.24M | -4.53M | -1.38M | -1.64M | -2.22M | 145.08M | -6.55M | -2.19M | |||||||||||
| Share-based Compensation | 0.37M | 0.42M | 0.30M | 1.56M | 0.68M | 0.93M | 0.71M | 0.47M | 0.55M | 0.55M | 0.44M | 0.44M | 0.05M | 0.04M | 0.04M | 0.03M | 0.02M | 0.02M | 0.01M | 0.03M | |||||||||||
| Cash from Discontinued Operations | -2.20M | -2.20M | |||||||||||||||||||||||||||||
| Gains from Sales and Divestitures | -137.73 | ||||||||||||||||||||||||||||||
| Cash from Operations | -7.08M | -2.77M | -15.95M | -5.25M | -6.05M | -2.79M | -17.06M | -2.55M | -3.07M | -2.55M | -9.01M | -2.51M | -3.05M | -0.46M | 3.14M | -0.67M | -0.51M | -0.67M | -0.77M | -0.98M | |||||||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||||||
| Amortization of Deferred Charges | 0.03M | 0.09M | -0.11M | 0.01M | 0.15M | -0.16M | 0.34M | 0.01M | -0.12M | 0.12M | -0.12M | 0.02M | 0.01M | ||||||||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.10M | 0.10M | 0.09M | 0.09M | 0.09M | 0.08M | 0.08M | 0.08M | 0.08M | 0.09M | 0.09M | 0.08M | 0.12M | 0.06M | 0.03M | 2.36M | -2.55M | 0.00M | 0.00M | 0.01M | |||||||||||
| Change in Working Capital | |||||||||||||||||||||||||||||||
| Change in Receivables | -0.06M | -0.08M | -0.10M | -0.22M | 0.04M | 0.04M | -0.26M | 0.20M | -0.03M | 0.08M | 0.08M | -0.01M | -0.52M | 0.12M | 0.53M | -0.02M | -0.00M | -0.02M | 0.04M | -0.02M | |||||||||||
| Change in Account Payables | -0.68M | -0.47M | 0.48M | 0.24M | 0.46M | -0.31M | -0.44M | 0.06M | -0.69M | -0.78M | -0.69M | 1.07M | -2.15M | -0.06M | 0.29M | 0.17M | 0.23M | 0.03M | 0.02M | -0.13M | |||||||||||
| Change in Accured Expenses | 0.01M | 0.04M | -0.16M | 0.02M | -0.03M | -0.00M | -0.01M | -0.03M | -0.01M | -0.01M | -0.07M | 0.75M | -0.75M | 0.00M | -0.08M | 0.00M | 918.00 | 0.00M | -0.01M | -0.01M | |||||||||||
| Other Working Capital Changes | -0.01M | -0.09M | -0.78M | 0.12M | -0.56M | -0.24M | 0.44M | 0.75M | -0.37M | 0.32M | -0.18M | 0.09M | -0.26M | ||||||||||||||||||
| Investing Activities | |||||||||||||||||||||||||||||||
| Change in Net Loans | 0.01M | 0.01M | 0.01M | 0.01M | -0.00M | -0.01M | 0.02M | -475.74 | -0.00M | -369.27 | 0.00M | ||||||||||||||||||||
| Capital Expenditures | 0.01M | -0.01M | -0.03M | -600.56 | -603.09 | -0.00M | -0.00M | -767.60 | -0.01M | ||||||||||||||||||||||
| Change in Intangibles | 94.35 | -8.30 | |||||||||||||||||||||||||||||
| Cash from Investing Activities | -0.00M | -567.44 | -0.03M | -9.34 | -0.00M | -0.00M | -767.60 | -0.01M | -0.01M | -0.02M | 1.07M | -0.00M | |||||||||||||||||||
| Financing Activities | |||||||||||||||||||||||||||||||
| Other financing activities | 0.03M | 0.01M | 0.02M | 0.01M | 0.43M | ||||||||||||||||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 0.26M | 0.27M | 0.94M | 1.43M | |||||||||||||||||||||||||||
| Net Equity Issued and Repurchased | |||||||||||||||||||||||||||||||
| Misc. | |||||||||||||||||||||||||||||||
| Cash from Financing Activities | -0.50M | -0.10M | 8.85M | -0.81M | -0.18M | 4.33M | -0.18M | -0.13M | 6.26M | -0.21M | -6.02M | 0.19M | -0.06M | -0.20M | 0.07M | 0.11M | 0.78M | 0.45M | 0.09M | 0.08M | |||||||||||
| Exchange Rate Effect | 0.00M | -0.00M | -0.20M | -0.01M | 215.96 | -9.32 | -0.20M | -0.03M | -0.00M | -293.23 | -0.40M | 0.11M | 0.00M | -0.04M | 0.04M | -0.02M | -0.02M | -0.00M | -0.00M | -0.00M | |||||||||||
| Change in Cash | -7.58M | 0.05M | 1.94M | -6.05M | -6.23M | 12.31M | -14.04M | -1.44M | 9.46M | -10.44M | 2.37M | -2.33M | 2.05M | -0.47M | -0.60M | -0.56M | -0.61M | -0.14M | 1.59M | -0.89M | |||||||||||
| Free Cash Flow | -7.09M | -2.75M | -15.91M | -5.25M | -6.05M | -2.79M | -17.06M | -2.55M | -3.06M | -2.55M | -9.00M | -2.51M | -3.05M | -0.46M | 3.14M | -0.67M | -0.51M | -0.67M | -0.77M | -0.98M | |||||||||||
| Net Cash Flow | -7.58M | -2.86M | -7.13M | -6.05M | -6.23M | 1.55M | -17.24M | -2.68M | 3.19M | -2.76M | -15.04M | -2.33M | -3.11M | -0.67M | 3.19M | -0.56M | 0.28M | 0.85M | -0.68M | -0.89M |